These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8361764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element.
    Zhang W, Guo XY, Deisseroth AB.
    Oncogene; 1994 Sep; 9(9):2513-21. PubMed ID: 8058314
    [Abstract] [Full Text] [Related]

  • 3. Inactive p53 mutants may enhance the transcriptional activity of wild-type p53.
    Zhang W, Shay JW, Deisseroth A.
    Cancer Res; 1993 Oct 15; 53(20):4772-5. PubMed ID: 8402659
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53.
    Abarzúa P, LoSardo JE, Gubler ML, Neri A.
    Cancer Res; 1995 Aug 15; 55(16):3490-4. PubMed ID: 7627952
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes.
    Harmes DC, Bresnick E, Lubin EA, Watson JK, Heim KE, Curtin JC, Suskind AM, Lamb J, DiRenzo J.
    Oncogene; 2003 Oct 23; 22(48):7607-16. PubMed ID: 14576823
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A, Resnick MA.
    Oncogene; 2001 Jun 07; 20(26):3409-19. PubMed ID: 11423991
    [Abstract] [Full Text] [Related]

  • 12. Activation of p53 DNA binding activity by point mutation.
    Marston NJ, Ludwig RL, Vousden KH.
    Oncogene; 1998 Jun 18; 16(24):3123-31. PubMed ID: 9671391
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerization are evolutionarily conserved.
    Wang Y, Farmer G, Soussi T, Prives C.
    Oncogene; 1995 Feb 16; 10(4):779-84. PubMed ID: 7862457
    [Abstract] [Full Text] [Related]

  • 15. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV, Das GC.
    Oncogene; 1996 Jul 18; 13(2):323-32. PubMed ID: 8710371
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
    Thornborrow EC, Patel S, Mastropietro AE, Schwartzfarb EM, Manfredi JJ.
    Oncogene; 2002 Feb 07; 21(7):990-9. PubMed ID: 11850816
    [Abstract] [Full Text] [Related]

  • 18. Distance constraints and stereospecific alignment requirements characteristic of p53 DNA-binding consensus sequence homologies.
    Cook JL, Ré RN, Giardina JF, Fontenot FE, Cheng DY, Alam J.
    Oncogene; 1995 Aug 17; 11(4):723-33. PubMed ID: 7651736
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.